Intervention Review

Pharmacotherapy for anxiety disorders in children and adolescents

  1. Jonathan C Ipser1,*,
  2. Dan J Stein2,
  3. Susan Hawkridge3,
  4. Lara Hoppe2

Editorial Group: Cochrane Depression, Anxiety and Neurosis Group

Published Online: 8 JUL 2009

Assessed as up-to-date: 7 AUG 2008

DOI: 10.1002/14651858.CD005170.pub2


How to Cite

Ipser JC, Stein DJ, Hawkridge S, Hoppe L. Pharmacotherapy for anxiety disorders in children and adolescents. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD005170. DOI: 10.1002/14651858.CD005170.pub2.

Author Information

  1. 1

    University of Stellenbosch, MRC Research Unit for Anxiety and Stress Disorders, Tygerberg, Western Cape, South Africa

  2. 2

    University of Cape Town, Department of Psychiatry and Mental Health, Cape Town, South Africa

  3. 3

    University of Stellenbosch, Department of Psychiatry, Tygerberg, South Africa

*Jonathan C Ipser, MRC Research Unit for Anxiety and Stress Disorders, University of Stellenbosch, PO Box 19063, Tygerberg, Western Cape, 7505, South Africa. jonathan.ipser@uct.ac.za. jonathanipser@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 JUL 2009

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Patrick D McGorry, Sherilyn D Goldstone, Alexandra G Parker, Debra J Rickwood, Ian B Hickie, Cultures for mental health care of young people: an Australian blueprint for reform, The Lancet Psychiatry, 2014, 1, 7, 559

    CrossRef

  2. 2
    Mathew L. Nguyen, Michael A. Shapiro, Stephen J. Welch, A case of severe adolescent obsessive-compulsive disorder treated with inpatient hospitalization, risperidone and sertraline, Journal of Behavioral Addictions, 2012, 1, 2, 78

    CrossRef

  3. 3
    Rebecca Rendleman, John T. Walkup, Swaiman's Pediatric Neurology, 2012,

    CrossRef

  4. 4
    Ian Kodish, Carol Rockhill, Sheryl Ryan, Chris Varley, Pharmacotherapy for Anxiety Disorders in Children and Adolescents, Pediatric Clinics of North America, 2011, 58, 1, 55

    CrossRef

  5. 5
    I. Simona Bujoreanu, Patricia Ibeziako, David Ray DeMaso, Psychiatric Concerns in Pediatric Epilepsy, Pediatric Clinics of North America, 2011, 58, 4, 973

    CrossRef

  6. 6
    Carol Rockhill, Ian Kodish, Caroline DiBattisto, Michelle Macias, Chris Varley, Sheryl Ryan, Anxiety Disorders in Children and Adolescents, Current Problems in Pediatric and Adolescent Health Care, 2010, 40, 4, 66

    CrossRef

  7. 7
    Ciara McCabe, Zevic Mishor, Philip J. Cowen, Catherine J. Harmer, Diminished Neural Processing of Aversive and Rewarding Stimuli During Selective Serotonin Reuptake Inhibitor Treatment, Biological Psychiatry, 2010, 67, 5, 439

    CrossRef

  8. 8
    I. Simona Bujoreanu, Patricia Ibeziako, David Ray DeMaso, Psychiatric Concerns in Pediatric Epilepsy, Child and Adolescent Psychiatric Clinics of North America, 2010, 19, 2, 371

    CrossRef

  9. 9
    Katharina Manassis, Kelly Russell, Amanda S. Newton, The Cochrane Library and the treatment of childhood and adolescent anxiety disorders: an overview of reviews, Evidence-Based Child Health: A Cochrane Review Journal, 2010, 5, 2
  10. 10
    Cara A. Settipani, Douglas M. Brodman, Jeremy Peterman, Kendra L. Read, Alexandra L. Hoff, Anna J. Swan, Philip C. Kendall, Anxiety Disorders in Children and Adolescents: Assessment and Treatment,
  11. 11
    Anthony C James, Georgina James, Felicity A Cowdrey, Angela Soler, Aislinn Choke, Cognitive behavioural therapy for anxiety disorders in children and adolescents, The Cochrane Library,
  12. 12
    Anna M Depping, Katja Komossa, Werner Kissling, Stefan Leucht, Second-generation antipsychotics for anxiety disorders, The Cochrane Library,